Stuart Cobb - 13 Mar 2024 Form 4 Insider Report for Neurogene Inc. (NGNE)

Role: Chief Scientific Officer
Signature: /s/ Christine Mikail, as attorney-in-fact for Stuart Cobb
Issuer symbol: NGNE
Transactions as of: 13 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 14 Mar 2024, 20:51:43 UTC
Previous filing: 26 Dec 2023
Next filing: 28 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NGNE	Common Stock	Award	$0	+20,391		$0.000000	20,391	13 Mar 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NGNE	Stock Option (Right to Buy)	Award	$0	+34,450		$0.000000	34,450	13 Mar 2024	Common Stock	34,450	$36.06	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests as to 1/4 of the total number of shares on March 13, 2025, and then 1/48 of the total number of shares will vest monthly thereafter, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date.